Last updated: June 24, 2026
POLMON pharmaceutical suppliers: who manufactures and supplies the product worldwide?
Polmon is a brand name used in multiple markets for different active ingredients and dosage forms. Without a specific country/active ingredient/dosage form (for example, syrup vs tablet vs injection; and the chemical name), supplier identification cannot be stated accurately.
Which companies supply POLMON in the US, EU, UK, and other markets?
No authoritative supplier list can be produced from the brand name alone because “POLMON” is not a unique identifier for a single drug product, active ingredient, or regulatory listing across jurisdictions.
What if POLMON is a rebranded product in different countries?
When a brand is used across markets, supply chains typically split by:
- local marketing authorization holder (MAH),
- product manufacturer (finished dose),
- API manufacturer (active ingredient),
- packager and secondary manufacturer (labeling, blistering, bottling),
- distributor network (tender supply, hospital supply, retail).
What “supplier” means for procurement
Procurement teams usually need one or more of:
- MAH (responsible under labeling and pharmacovigilance),
- contract manufacturer (finished dose),
- API supplier (if planning tech transfer or parallel manufacturing),
- logistics distributor (if buying for tenders/wholesale).
What active ingredient is POLMON, and who are the API and finished-dose suppliers?
A complete supplier mapping requires the exact active ingredient and dosage form tied to the specific POLMON product. Brand-name-only searches do not reliably yield:
- the correct API,
- the correct formulation,
- the correct marketing authorization,
- the correct manufacturing sites.
What does the FDA, EMA, MHRA, or local authority listing show for POLMON?
Orange Book-style supplier mapping applies only when:
- the product is FDA-approved with an NDC tied to a specific label,
- or the EU has an EPAR/SmPC with MAH and manufacturer information,
- or the UK has MHRA registration data aligned to the same product.
Brand-name-only inputs can match multiple different products, so supplier status by authority cannot be stated as a single set of companies.
How do hospital and retail distribution channels change POLMON suppliers?
Even within one country, suppliers can differ by channel:
- hospital tenders may award to one wholesale distributor and one primary manufacturer,
- retail may rely on parallel distribution or secondary packaging by a different site,
- procurement may split by pack size and strength.
Without the exact product label, pack strength, and market, channel-level supplier identification cannot be completed.
Which manufacturers typically supply branded POLMON products like tablets, syrup, or injections?
No product-specific manufacturer set can be provided from the brand name alone. Different dosage forms and actives for “POLMON” typically have different:
- sterile vs non-sterile manufacturing constraints,
- formulation excipient systems,
- packaging (blister vs bottle vs vial),
- quality systems and line clearances,
- regulatory documentation and batch-release networks.
What supplier documents do buyers use to qualify POLMON sources?
For sourcing, buyers typically request:
- GMP certificate(s) for the finished-dose site,
- GMP certificate(s) for API manufacturing sites (as applicable),
- COA and batch-release testing evidence,
- supply agreement with MAH responsibility chain,
- labeling and artwork approvals,
- pharmacovigilance system confirmation (for MAH role),
- serialization and track-and-trace compliance (market dependent).
These documents are product-specific and cannot be mapped to POLMON without the exact registration details.
Key Takeaways
- “POLMON” is not enough to identify a single, correct supplier set.
- Supplier mapping must be tied to the exact active ingredient, dosage form, and target market/regulatory listing.
- Without that linkage, API and finished-dose manufacturers, MAH, and distribution partners cannot be stated accurately.
FAQs
-
How can I find the MAH for POLMON in my country?
Use the national drug registry tied to the exact active ingredient and strength, not the brand alone.
-
Who is the API supplier for POLMON?
The API supplier depends on the exact product label (active ingredient and strength) and manufacturing chain for that specific jurisdiction.
-
Is POLMON manufactured by the same company in every market?
No. Brand naming can be used across different formulations and different MAHs and contract manufacturers by country.
-
Does POLMON have different suppliers for syrup versus tablets?
Typically yes, because dosage form and formulation drive different manufacturing lines and quality requirements.
-
What supplier information is available through Orange Book or EPAR listings?
Only if POLMON can be matched to a specific approved product record (NDC/EPAR/SmPC) for the market in question.
References
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
- EMA. EPAR database. European Medicines Agency.
- MHRA. Medicines guidance and licensing information. Medicines and Healthcare products Regulatory Agency.
